MOSO stock analysis – MSOS sold off & here is why it will keep going up

The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control in patients ages 10 and older with

MASH is a form of non-alcoholic liver disease. Credit: SEBASTIAN KAULITZKI / SCIENCE PHOTO LIBRARY via Getty Images. Eli Lilly is paying up to $630m

Cal­i­for­nia biotech Al­to Neu­ro­science has filed to go pub­lic as it runs two Phase IIb tri­als for its two lead ma­jor de­pres­sive dis­or­der drug can­di­dates.